WHO ICTRP trial
The Effect of Methotrexate on Fertility Parameters in Men with Immune Mediated…
NL-OMON20969 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON20969 |
|---|---|
| Public title | The Effect of Methotrexate on Fertility Parameters in Men with Immune Mediated Diseases |
| Scientific title | The Effect of Methotrexate on Fertility Parameters in Men with Immune Mediated Diseases |
| Primary sponsor | Erasmus MC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Conditions | Immune-mediated diseases such as Rheumatoid Arthritis (RA), Spondyloartropathies (SpA), Juvenile Idiopathic Arthritis (JIA), Undifferentiated Arthritis (UA), Psoriasis (PsO), eczema (E) and Crohn’s Disease (CD). |
| Interventions | Not applicable. |
| Registration date | May 20, 2020 |
| Target size | 50 |
| Secondary IDs | NL8674;METC Erasmus MC : MEC-2018-082 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: